Trial intelligence / Profile preview

Trigger-point Blockade in Persistent Pain After Laparoscopically Assisted Groin Hernia Repair

NCT02065804Phase 3Completed

Sponsor
University of Copenhagen
Start
Oct 2013
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupivacaine in chronic pain, sponsored by University of Copenhagen. Started Oct 2013; status: completed.

02

Drugs

bupivacaine
03

Conditions

chronic pain

Beyond the preview

Go deeper on NCT02065804.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02065804.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call